ARATANA THERAPEUTICS INC. news, videos and press releases
For more news please use our advanced search feature.
ARATANA THERAPEUTICS INC. - More news...
ARATANA THERAPEUTICS INC. - More news...
- Aratana Therapeutics' Stockholders Adopt Merger Agreement with Elanco Animal Health
- Aratana Therapeutics Reports Voting Results from 2019 Annual Meeting of Stockholders
- Aratana Therapeutics Reports First Quarter 2019 Financial Results
- Aratana Therapeutics to Present at Stifel 2019 Dental & Veterinary Conference
- Aratana Therapeutics, Inc. - PETX Stock Chart Technical Analysis for 04-26-2019
- ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aratana Therapeutics, Inc.
- Aratana Therapeutics to be Acquired by Elanco Animal Health
- Aratana Therapeutics to Report First Quarter 2019 Financial Results
- Aratana Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
- Aratana Therapeutics to Participate at Upcoming Investment Conferences
- Aratana Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results
- Aratana Therapeutics Appoints Rhonda Hellums Chief Financial Officer
- Aratana Therapeutics' Board of Directors Appoints Craig Tooman Chief Executive Officer
- Aratana Therapeutics Reports Third Quarter 2018 Financial Results
- Aratana Therapeutics to Report Third Quarter 2018 Financial Results
- Aratana Therapeutics to Present at CL King and Associates Best Ideas Conference
- Aratana Therapeutics Reports Second Quarter 2018 Financial Results
- Aratana Therapeutics to Report Second Quarter 2018 Financial Results
- Aratana Therapeutics Files for FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) Label Expansion
- Aratana Therapeutics to Participate at Jefferies 2018 Global Healthcare Conference
- Aratana Therapeutics Appoints Craig Barbarosh and Lowell Robinson to its Board of Directors in Cooperation Agreement with Engaged Capital
- Aratana Therapeutics Reports First Quarter 2018 Financial Results
- Aratana Therapeutics to Report First Quarter 2018 Financial Results
- Aratana Therapeutics Confirms Receipt of Board Nominations
- Aratana Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
- Aratana Therapeutics to Participate at Upcoming Investment Conferences
- Aratana Therapeutics Expands Therapeutic Candidate Pipeline
- Aratana Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results
- GALLIPRANT® (grapiprant tablets) Named Best Companion Animal Product for 2017
- Aratana Therapeutics Announces Study Results for AT-016